Articles and Insights About Wearables for Clinical Trials

VivoSense Announces Closing of $25M Series A Financing

Posted by Dudley Tabakin on March 30, 2022

Proceeds to accelerate the collection and use of wearable sensor data in clinical trials along with the development of novel digital biomarkers.

Funding round co-led by the Perceptive Xontogeny Venture (PXV) Fund and Switzerland-based Debiopharm Innovation Fund.

NEWPORT BEACH, Calif. – March 30, 2022-- VivoSense, Inc., (“VivoSense”) an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data, today announced the close of a $25 Million Series A financing round. The financing will accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments (COAs). VivoSense will also use this financing to expand and refine its informatics platform for data analysis from wearable and connected technologies to deliver validated digital COAs for life science research.

Read More

How to Visualize Physiological Data for Clinical Trials Using VivoSense®

Posted by Dudley Tabakin on February 10, 2022

The best way to understand how VivoSense®️ software can help you visualize physiological data from your clinical trial is to see it in action. The first video below will take you through the graphical user interface, importing and opening a physiological data session, and exploring the data with the Data Explorer panel and the synchronized chart panel.

The second video will discuss some advanced tools, such as the channel chart and plot properties, create some save layouts for use with all data sessions, create annotation markings to identify events in the data, and export the data to ASCII.

Read More

Employee Spotlight: Patrick Hankey, PhD.

Posted by VivoSense Team on January 28, 2022

Our Employee Spotlight series highlights a different team member each month, offering a behind-the-scenes look at the people integral to our success. This month, we are speaking with one of our company founders, Patrick Hankey, PhD., VP of Business Development.

Read More

Catalyze Digital Biomarker Innovation Through Collaboration

Posted by Kate Lyden on January 27, 2022

Industry and academia each play important roles in advancing wearable technologies and digital biomarkers to develop life-changing drugs and therapies. Still, successful relationships between the two groups are not nearly as prevalent as they could – or should – be. In this presentation, Kate Lyden, VivoSense Chief Science Officer, discusses the motivation for academia and industry to work together, where the overlap lies, and opportunities for moving forward together.

Read More

Advancing Novel Respiratory Endpoint Discovery with Wearables

Posted by VivoSense Team on January 18, 2022

The adoption of wearables into clinical trials is fostering innovative ideas about novel digital biomarker development. The following articles discuss strategies for developing respiratory endpoints using real-world data and a patient-centered approach. Learn more and advance ideas for your next research project!

Read More

Digital Biomarkers: Current Limitations and Future Outlook

Posted by Kate Lyden on December 23, 2021

There’s an undeniable push to drive innovation for a new age of precision medicine. At the 2021 Digital Biomarkers & Digital Measurements Summit, Kate Lyden, VivoSense Chief Science Officer, joined a panel of experts to discuss the future of digital biomarkers and advancing medicine toward a patient-oriented, decentralized, tech-enabled approach. Here is a quick snap-shot of her key takeaways.

Read More

Example of Novel Respiratory Endpoint Discovery Using Real-World Data

Posted by Dudley Tabakin on December 1, 2021

In this video, Dudley Tabakin, VivoSense CEO, shares an example of how rare disease researchers can use wearable sensors to develop digital clinical measures to improve patient outcomes. He discusses our approach to developing outcome measures from ECG Derived Respiration (EDR) to discover novel respiratory endpoints for Rett Syndrome, working with Rett Syndrome Research Trust.

Read More

Understanding Neurodegenerative Diseases with Wearable Sensors

Posted by Jen Blankenship on November 4, 2021

Millions of people across the globe struggle with neurodegenerative diseases every day. Neurodegenerative diseases are characterized by a breakdown of the central and peripheral nervous systems and cause progressive deterioration of a normally functioning human body. However, a significant challenge in studying neurodegenerative diseases is that direct measurements of neurological systems are invasive and expensive.

Wearable sensors can be used to understand disease progression and manifestation by measuring physical symptoms and physiological outcomes.

Read More

The Value of Exploratory Endpoints in Early Phase Clinical Trials

Posted by Kate Lyden on October 5, 2021

Drug development and clinical care models continue to take a more patient-centered approach. Putting the patient at the center of all phases of medicine is a shift initiated by the FDA. Systematic governance and policy development are currently underway.

A key component to supporting this paradigm shift is the use of real-world evidence collected with wearable sensors. Despite their enormous potential and the pharmaceutical industry’s enthusiasm for their incorporation into drug trials, the majority of digital clinical measures continue to require development – primarily, context-specific clinical validation.

Read More

Employee Spotlight: Dudley Tabakin

Posted by VivoSense Team on September 23, 2021

Our Employee Spotlight series highlights a different team member each month, offering a behind-the-scenes look into the people who are an integral part of our success. This month we are talking to Dudley Tabakin, CEO and co-founder.

Read More

Subscribe to Email Updates

Stay Connected

Popular